ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
AB Corporate Bond ETF

AB Corporate Bond ETF (EYEG)

36.23
0.015
( 0.04% )
Updated: 13:20:50

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
36.23
Bid
36.19
Ask
36.24
Volume
28,717
36.23 Day's Range 36.25
34.52 52 Week Range 37.24
Market Cap
Previous Close
36.215
Open
36.25
Last Trade
3485
@
36.23
Last Trade Time
10:34:17
Financial Volume
$ 1,040,445
VWAP
36.231
Average Volume (3m)
720
Shares Outstanding
7,689,000
Dividend Yield
-
PE Ratio
-1.99
Earnings Per Share (EPS)
-1.7
Revenue
-
Net Profit
-13.05M

About AB Corporate Bond ETF

The Fund is an actively-managed exchange-traded fund (ETF). The Fund pursues its objective by investing, under normal circumstances, at least 80% of its net assets, including any borrowings for investment purposes, in investment grade fixed-income securities of corporate issuers. Corporate issuers m... The Fund is an actively-managed exchange-traded fund (ETF). The Fund pursues its objective by investing, under normal circumstances, at least 80% of its net assets, including any borrowings for investment purposes, in investment grade fixed-income securities of corporate issuers. Corporate issuers may include corporate or other business entities in which a sovereign or governmental agency or entity may have, indirectly or directly, an interest, including a majority or greater ownership interest. The Funds investment objective is to maximize total return through current income and longterm capital appreciation. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
AB Corporate Bond ETF is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker EYEG. The last closing price for AB Corporate Bond ETF was $36.22. Over the last year, AB Corporate Bond ETF shares have traded in a share price range of $ 34.52 to $ 37.24.

AB Corporate Bond ETF currently has 7,689,000 shares outstanding. The market capitalization of AB Corporate Bond ETF is $278.46 million. AB Corporate Bond ETF has a price to earnings ratio (PE ratio) of -1.99.

EYEG Latest News

EyeGate Pharmaceuticals to Present at BIO CEO & Investor Conference in New York City

WALTHAM, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today announced that the Company will attend and present at the 21st...

EyeGate Pharmaceuticals Announces Meeting Date with FDA

WALTHAM, Mass., Jan. 16, 2019 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today confirmed that it is scheduled to meet with the U.S. Food and...

EyeGate Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update

WALTHAM, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today announced financial results for the three-month period ended...

EyeGate Pharma Announces Positive Results in Second PRK Study

Data confirms results from earlier study WALTHAM, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) today announced top-line data from its study evaluating...

EyeGate Pharmaceuticals Signs Technology Transfer and License Agreement with SentrX Animal Care

WALTHAM, Mass., Oct. 02, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Pharmaceuticals Granted Additional 180 Days to Comply With Nasdaq Listing Rules

WALTHAM, Mass., Sept. 25, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Pharmaceuticals Completes Enrollment in Both PRK and PE Pilot Studies

WALTHAM, Mass., Sept. 24, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Announces Randomization of First Patients in Study for Punctate Epitheliopathies

WALTHAM, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Announces Top-Line Results for Phase 3 Trial of EGP-437 in Anterior Uveitis

WALTHAM, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.210.583009439236.0236.291636.027036.10041643SP
40.310.86302895322935.9236.291635.683936.08247416SP
12-0.62-1.6824966078736.8537.2435.672036.4990279SP
261.13.1312268716235.1337.2435.018463836.40445519SP
521.032.9261363636435.237.2434.5255035.88541152SP
1561.032.9261363636435.237.2434.5255035.88541152SP
2601.032.9261363636435.237.2434.5255035.88541152SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CTNTCheetah Net Supply Chain Service Inc
$ 5.24
(180.21%)
107.44M
ZJKZJK Industrial Company Ltd
$ 14.68
(131.55%)
20.43M
GWAVGreenwave Technology Solutions Inc
$ 0.6048
(65.70%)
399.39M
JYDJayud Global Logistics Ltd
$ 1.0792
(61.05%)
9.35M
JANXJanux Therapeutics Inc
$ 62.185
(54.77%)
5.28M
REVBRevelation Biosciences Inc
$ 0.5532
(-41.76%)
3.83M
OMEXOdyssey Marine Exploration Inc
$ 0.4752
(-36.23%)
3.53M
STSSSharps Technology Inc
$ 2.235
(-33.36%)
377.67k
CYCNCyclerion Therapeutics Inc
$ 1.61
(-31.20%)
266.25k
GELSGelteq Ltd
$ 2.703
(-29.25%)
224.97k
GWAVGreenwave Technology Solutions Inc
$ 0.6048
(65.70%)
399.45M
SMCISuper Micro Computer Inc
$ 40.86
(-2.71%)
169.47M
CTNTCheetah Net Supply Chain Service Inc
$ 5.24
(180.21%)
108.99M
CHRSCoherus BioSciences Inc
$ 1.88
(37.23%)
102.71M
NVDANVIDIA Corporation
$ 138.9509
(0.23%)
101.13M

Discussion

View Full Feed
weedtrader420 weedtrader420 3 minutes ago
XRP 🏋️ AMERICAN PIE
XRPUSD
Mark Mark 3 minutes ago
$EDBL .17 ww
EDBL
janetcanada janetcanada 3 minutes ago
👀***List of people granted executive clemency by Donald Trump

👀***Donald Trump granted executive clemency to 237 individuals charged or convicted of federal criminal offenses, using his clemency power under Article II, ...
GRST
train train 4 minutes ago
I picked up some more shs this morning. I think it will go up soon.

Charlie
Williamsburg, Va.
AKEMF
HoldEm777 HoldEm777 4 minutes ago
It wasn’t to mislead just me. It was to mislead everyone. But I used to be quick to believe everything. I was low hanging fruit with a inheritance who had no business trading.
Trading doesn’t operate the way I was raised to be. So it was inner turmoil. I took it personally. Not so much anymo
RDAR
flipper44 flipper44 4 minutes ago
Edit. Apparently ‘intact’ is one word not two.🤗
NWBO
Mark Mark 4 minutes ago
$APDN .195
APDN
STL Stock STL Stock 4 minutes ago
Sometimes lightning strikes twice in the OTC. It's getting interesting.
HMBL
stock1ace1 stock1ace1 5 minutes ago
$NBIS $28 Trading open gap room to $34
SPANISH_gladiator SPANISH_gladiator 5 minutes ago
absolutly no
RMTD
igotthemojo igotthemojo 5 minutes ago
"I am bullish for the LT"

i dont see how...they just hit yet ANOTHER all time low...they did a 1-30 r/s back in June...pre-split, the stock is currently at a nickel per share...bullish for the long term?...seiously?..

"(or maybe that would not have worked)"
NKLA
Konaploinks Konaploinks 5 minutes ago
I could hear the first part but then the second half was mostly garbled on my phone. I have very poor cell service at my house. In the first part I heard about us working with the U S Air Force on a “quantum internet” . That sounded interesting. The rest was basically about working with our new part
IONQ
MeteoricChimera43 MeteoricChimera43 5 minutes ago
100% agree and they had a line of credit that they never used in 2023
RVNC
Shareing is winning Shareing is winning 6 minutes ago
https://ih.advfn.com/stock-market/NASDAQ/coherus-biosciences-CHRS/stock-news/95025208/form-defa14a-additional-definitive-proxy-solicit
CHRS
adam123 adam123 6 minutes ago
Are you adding in here?
MLGO
MartinLutherKing MartinLutherKing 6 minutes ago
Non believers have left the spaceship 🚀🚀🚀
RNAZ
Lone Clone Lone Clone 6 minutes ago
Impact Silver Intersects 16.60% Zinc over 2.5m and 27.50% Zinc over 1.1m at the Plomosas Mine

https://www.newsfilecorp.com/release/232308/Impact-Silver-Intersects-16.60-Zinc-over-2.5m-and-27.50-Zinc-over-1.1m-at-the-Plomosas-Mine

December 03, 2024 11:51 AM EST | Source
ISVLF
MrSmith101 MrSmith101 6 minutes ago
Reviews: "**BEWARE** STAY AWAY FROM ARIA
Management is Absolutely horrible at this place.Staff shortages, experienced staff abandoning ship and moving on..Systemic problems went unresolved in my days there.So much that I left for another facility to continue my treatment.."

"Wo
GRST
JustGoDeep JustGoDeep 6 minutes ago
Now Get Back To Work For Me!! lmao
BIEL
lighter than AIR lighter than AIR 6 minutes ago
As I said, I never spoke to anyone but the receptionist…and didn’t get much from her.
I left a message for a foreman but never got a returned call, so decided not to push it.
CBRF
LowFloatLopes LowFloatLopes 6 minutes ago
Blue skies on a cloudy day 
JASMYUSD
Lone Clone Lone Clone 6 minutes ago
Impact Silver Intersects 16.60% Zinc over 2.5m and 27.50% Zinc over 1.1m at the Plomosas Mine

https://www.newsfilecorp.com/release/232308/Impact-Silver-Intersects-16.60-Zinc-over-2.5m-and-27.50-Zinc-over-1.1m-at-the-Plomosas-Mine

December 03, 2024 11:51 AM EST | Source
NoMoDo NoMoDo 6 minutes ago
If the market cap is $6 mil, the $20 mil asset hmbl just got in exchange for controlling interest - foote's 7 mil pref c shared - immediately brings the value to 3x current price. 

Foote gave up control for a nice payday for us - so much for the scam theories. Foote will also benefit
HMBL
RIGATONI RIGATONI 6 minutes ago
~CAPR $16.92 Bought the dip ~Rig
CAPR
Mark Mark 6 minutes ago
$APDN blew thru .18s
APDN